PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1

  • Wang Y
  • Hasegawa M
  • Imamura R
 et al. 
  • 51


    Mendeley users who have this article in their library.
  • 85


    Citations of this article.


Recently, a large subfamily of nucleotide-binding and oligomerization domain-containing proteins that have an N-terminal pyrin-like domain and C-terminal leucine-rich repeats has been described. In this study, we identified PYNOD, a novel member of this family that lacks the leucine-rich repeats. We found that human PYNOD mRNA is expressed in various tissues and at high levels in heart, skeletal muscle and brain. It is also expressed in various cell lines, including haematopoietic cell lines. PYNOD oligomerizes and binds to ASC, an adaptor protein that plays a role in apoptotic and inflammatory signal transduction, and to caspase-1 and IL-1beta. PYNOD inhibits apoptosis-associated speck-like protein containing a CARD (ASC)-mediated NF-kappaB activation and apoptosis, and caspase-1-mediated IL-1beta maturation, and it does so in the presence and absence of constitutively active mutants of CARD12 and PYPAF1, which are enhancers of these processes. Thus, PYNOD is a novel regulator of apoptosis and inflammation.

Author-supplied keywords

  • Apoptosis
  • IL-1β
  • Inflammation
  • NF-κB

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Yetao Wang

  • Mizuho Hasegawa

  • Ryu Imamura

  • Takeshi Kinoshita

  • Chiaki Kondo

  • Kenji Konaka

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free